IGF1 and glioblastoma: The RNA-sequencing analysis of both tumoral cells and GAMMs revealed elevated PI3K pathway activity in recurrent GBM, driven by GAMM-derived IGF-1 and tumor cell IGF-1 receptor (IGF-1R) [86].